All are classical signs of sarcopenia and none were detectable at 4 months of age, indicating that the deficit of STIM1 is more efficiently compensated at a younger age or that insufficient SOCE entails rising dysregulations of Ca2+‐dependent signalling pathways, which lead to a progressive decrease in muscle performances. The gene discussed is STIM1; the disease is sarcopenia.